NO20091830L - Spiro-piperidinderivater som VIa reseptorantagonister - Google Patents
Spiro-piperidinderivater som VIa reseptorantagonisterInfo
- Publication number
- NO20091830L NO20091830L NO20091830A NO20091830A NO20091830L NO 20091830 L NO20091830 L NO 20091830L NO 20091830 A NO20091830 A NO 20091830A NO 20091830 A NO20091830 A NO 20091830A NO 20091830 L NO20091830 L NO 20091830L
- Authority
- NO
- Norway
- Prior art keywords
- spiro
- receptor antagonists
- piperidine derivatives
- via receptor
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pregnancy & Childbirth (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Foreliggende oppfinnelse angår nye indol-2-yl-karbonyl-spiro-piperidin-derivater som VIa reseptorantagonister, fremstilling av dem, farmasøytiske preparater inneholdende dem og anvendelse av dem som medikamenter. De aktive forbindelser ifølge foreliggende oppfinnelse er anvendelige for forebygging og/eller behandling av angst og depressive lidelser og andre sykdommer. Forbindelsene ifølge foreliggende oppfinnelse er representert ved den generelle formel (I) hvor R1 til R11, X og Y er som definert i beskrivelsen.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06125634 | 2006-12-07 | ||
PCT/EP2007/062985 WO2008068185A1 (en) | 2006-12-07 | 2007-11-29 | Spiro-piperidine derivatives as via receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20091830L true NO20091830L (no) | 2009-07-06 |
Family
ID=39295880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20091830A NO20091830L (no) | 2006-12-07 | 2009-05-11 | Spiro-piperidinderivater som VIa reseptorantagonister |
Country Status (21)
Country | Link |
---|---|
US (3) | US8202993B2 (no) |
EP (1) | EP2102207B1 (no) |
JP (1) | JP2010511661A (no) |
KR (1) | KR101050568B1 (no) |
CN (1) | CN101547923A (no) |
AR (1) | AR064135A1 (no) |
AT (1) | ATE469900T1 (no) |
AU (1) | AU2007328995B2 (no) |
BR (1) | BRPI0720004A2 (no) |
CA (1) | CA2670674A1 (no) |
CL (1) | CL2007003482A1 (no) |
DE (1) | DE602007006990D1 (no) |
ES (1) | ES2344131T3 (no) |
IL (1) | IL198544A (no) |
MX (1) | MX2009005504A (no) |
NO (1) | NO20091830L (no) |
PE (1) | PE20081252A1 (no) |
RU (1) | RU2009119394A (no) |
TW (1) | TW200838518A (no) |
WO (1) | WO2008068185A1 (no) |
ZA (1) | ZA200903496B (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008077810A2 (en) | 2006-12-22 | 2008-07-03 | F. Hoffmann-La Roche Ag | Spiro-piperidine derivatives |
BRPI0911577B8 (pt) | 2008-04-29 | 2021-05-25 | Novartis Ag | derivados espiro-indol, seus usos no tratamento de doenças parasíticas, e composição farmacêutica |
CA2963188A1 (en) * | 2014-11-14 | 2016-05-19 | F. Hoffmann-La Roche Ag | Spiro-thiazolones |
WO2017137334A1 (en) * | 2016-02-08 | 2017-08-17 | F. Hoffmann-La Roche Ag | Spiroindolinones as ddr1 inhibitors |
MX2020002436A (es) * | 2017-09-05 | 2020-07-13 | Blackthorn Therapeutics Inc | Antagonistas del receptor de vasopresina y productos y metodos relacionados a los mismos. |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3370091A (en) | 1964-06-15 | 1968-02-20 | Hoffmann La Roche | 2 aminobenzhydrylhalides |
US3531467A (en) | 1966-12-23 | 1970-09-29 | Hoffmann La Roche | Process for the preparation of 2,3,4,5-tetrahydro - 5 - aryl - 1h - 1,4 - benzodiazepine derivatives |
US4209625A (en) | 1977-04-21 | 1980-06-24 | American Hoechst Corporation | Spiro[indoline-3,4'-piperidine]s |
DE3818830A1 (de) * | 1988-06-03 | 1989-12-14 | Boehringer Mannheim Gmbh | Bicyclische carboxamide, verfahren zu ihrer herstellung, deren vorstufen, und diese verbindungen enthaltende arzneimittel |
EP0450761A1 (en) * | 1990-03-02 | 1991-10-09 | Merck & Co. Inc. | Spirocyclic oxytocin antagonists |
DK78692D0 (da) | 1992-06-12 | 1992-06-12 | Lundbeck & Co As H | Dimere piperidin- og piperazinderivater |
WO1994007496A1 (en) | 1992-10-07 | 1994-04-14 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
US5670509A (en) | 1993-09-27 | 1997-09-23 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
IT1271026B (it) | 1994-10-21 | 1997-05-26 | Isagro Ricerca Srl | Derivati dell'acido b-amminopropionico ad attivita' fungicida |
US5576321A (en) | 1995-01-17 | 1996-11-19 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
IL124459A0 (en) | 1995-12-14 | 1998-12-06 | Merck & Co Inc | Antagonists of gonadotropin releasing hormone |
GB9601724D0 (en) * | 1996-01-29 | 1996-03-27 | Merck Sharp & Dohme | Therapeutic agents |
US6166209A (en) | 1997-12-11 | 2000-12-26 | Hoffmann-La Roche Inc. | Piperidine derivatives |
CO5150201A1 (es) | 1998-09-07 | 2002-04-29 | Hoffmann La Roche | Derivados de piperidina |
TWI279402B (en) | 1999-08-20 | 2007-04-21 | Banyu Pharma Co Ltd | Spiro compounds having NPY antagonistic activities and agents containing the same |
GB0003397D0 (en) | 2000-02-14 | 2000-04-05 | Merck Sharp & Dohme | Therapeutic agents |
CN1174979C (zh) | 2000-05-12 | 2004-11-10 | 索尔瓦药物有限公司 | 哌嗪和哌啶化合物 |
ES2220811T3 (es) | 2000-09-29 | 2004-12-16 | Eli Lilly And Company | Procedimiento y compuestos para el tratamiento de enfermedades proliferativas. |
US6596718B1 (en) | 2001-11-27 | 2003-07-22 | Hoffmann-La Roche Inc. | 7-Morpholin-4yl-benzothiazole amide derivatives |
FR2833948B1 (fr) | 2001-12-21 | 2004-02-06 | Sod Conseils Rech Applic | Nouveaux derives de benzimidazole et leur utilisation en tant que medicament |
US20040152741A1 (en) | 2002-09-09 | 2004-08-05 | Nps Allelix Corporation | Arylglycine derivatives and their use as glycine transport inhibitors |
WO2004026855A1 (en) | 2002-09-20 | 2004-04-01 | H. Lundbeck A/S | Method for manufacture of dihydroisobenzofuran derivatives |
JP2006505570A (ja) | 2002-10-17 | 2006-02-16 | アムジエン・インコーポレーテツド | ベンズイミダゾール誘導体およびそれのバニロイド受容体リガンドとしての使用 |
WO2004069809A1 (en) | 2003-02-03 | 2004-08-19 | Janssen Pharmaceutica N.V. | Mercaptoimidazoles as ccr2 receptor antagonists |
US7244852B2 (en) | 2003-02-27 | 2007-07-17 | Abbott Laboratories | Process for preparing 2-methylpyrrolidine and specific enantiomers thereof |
JP4629657B2 (ja) * | 2003-04-11 | 2011-02-09 | ハイ・ポイント・ファーマスーティカルズ、エルエルシー | 11β−ヒドロキシステロイドデヒドロゲナーゼ1型化活性化合物 |
MXPA06005038A (es) | 2003-11-04 | 2007-12-12 | Elixir Pharmaceuticals Inc | Compuestos terapeuticos y usos de los mismos. |
AP2331A (en) * | 2003-12-22 | 2011-12-05 | Pfizer | Triazole derivatives as vasopressin antagonists. |
EP1716148A2 (en) | 2003-12-23 | 2006-11-02 | Arena Pharmaceuticals, Inc. | Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof |
GB0400700D0 (en) * | 2004-01-13 | 2004-02-18 | Pfizer Ltd | Compounds useful in therapy |
KR100854864B1 (ko) | 2004-08-05 | 2008-08-28 | 에프. 호프만-라 로슈 아게 | 인돌, 인다졸 또는 인돌린 유도체 |
US8138342B2 (en) | 2004-10-12 | 2012-03-20 | High Point Pharmacueticals, LLC | 11β-hydroxysteroid dehydrogenase type 1 active spiro compounds |
US8599298B2 (en) * | 2004-10-13 | 2013-12-03 | Sony Corporation | Reproduction apparatus, imaging apparatus, screen display method, and user interface |
WO2006123242A1 (en) | 2005-05-18 | 2006-11-23 | Pfizer Limited | 1, 2, 4 -triazole derivatives as vasopressin antagonists |
US8190027B2 (en) | 2006-07-12 | 2012-05-29 | Tellabs Operations, Inc. | Multifunctional and reconfigurable optical node and optical network |
BRPI0612988A2 (pt) | 2005-07-14 | 2010-12-14 | Hoffmann La Roche | derivados de indol-3-il-carbonil-espiro-piperidina como antagonistas de receptor v1a |
EP1943250A1 (en) | 2005-09-09 | 2008-07-16 | Euro-Celtique S.A. | Fused and spirocycle compounds and the use thereof |
WO2008077810A2 (en) | 2006-12-22 | 2008-07-03 | F. Hoffmann-La Roche Ag | Spiro-piperidine derivatives |
ATE486877T1 (de) | 2006-12-29 | 2010-11-15 | Hoffmann La Roche | Azaspiroderivate |
ATE536356T1 (de) | 2007-01-12 | 2011-12-15 | Hoffmann La Roche | Spiropiperidin-glycinamid-derivate |
-
2007
- 2007-11-29 CN CNA2007800448317A patent/CN101547923A/zh active Pending
- 2007-11-29 ES ES07847502T patent/ES2344131T3/es active Active
- 2007-11-29 WO PCT/EP2007/062985 patent/WO2008068185A1/en active Application Filing
- 2007-11-29 MX MX2009005504A patent/MX2009005504A/es active IP Right Grant
- 2007-11-29 KR KR1020097011665A patent/KR101050568B1/ko not_active IP Right Cessation
- 2007-11-29 EP EP07847502A patent/EP2102207B1/en not_active Not-in-force
- 2007-11-29 AU AU2007328995A patent/AU2007328995B2/en not_active Expired - Fee Related
- 2007-11-29 CA CA002670674A patent/CA2670674A1/en not_active Abandoned
- 2007-11-29 DE DE602007006990T patent/DE602007006990D1/de active Active
- 2007-11-29 BR BRPI0720004-8A patent/BRPI0720004A2/pt not_active IP Right Cessation
- 2007-11-29 JP JP2009539707A patent/JP2010511661A/ja active Pending
- 2007-11-29 AT AT07847502T patent/ATE469900T1/de active
- 2007-11-29 RU RU2009119394/04A patent/RU2009119394A/ru not_active Application Discontinuation
- 2007-11-30 US US11/947,953 patent/US8202993B2/en not_active Expired - Fee Related
- 2007-11-30 US US11/947,934 patent/US20080146568A1/en not_active Abandoned
- 2007-11-30 US US11/947,967 patent/US20080139554A1/en not_active Abandoned
- 2007-12-04 TW TW096146114A patent/TW200838518A/zh unknown
- 2007-12-04 CL CL200703482A patent/CL2007003482A1/es unknown
- 2007-12-05 AR ARP070105426A patent/AR064135A1/es unknown
- 2007-12-06 PE PE2007001736A patent/PE20081252A1/es not_active Application Discontinuation
-
2009
- 2009-05-04 IL IL198544A patent/IL198544A/en not_active IP Right Cessation
- 2009-05-11 NO NO20091830A patent/NO20091830L/no not_active Application Discontinuation
- 2009-05-20 ZA ZA200903496A patent/ZA200903496B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0720004A2 (pt) | 2013-12-17 |
WO2008068185A1 (en) | 2008-06-12 |
US20080146568A1 (en) | 2008-06-19 |
PE20081252A1 (es) | 2008-09-04 |
ZA200903496B (en) | 2010-03-31 |
AU2007328995A1 (en) | 2008-06-12 |
EP2102207B1 (en) | 2010-06-02 |
DE602007006990D1 (de) | 2010-07-15 |
CL2007003482A1 (es) | 2008-07-04 |
CA2670674A1 (en) | 2008-06-12 |
IL198544A (en) | 2012-06-28 |
AR064135A1 (es) | 2009-03-18 |
CN101547923A (zh) | 2009-09-30 |
US20080139554A1 (en) | 2008-06-12 |
IL198544A0 (en) | 2010-02-17 |
MX2009005504A (es) | 2009-06-03 |
ATE469900T1 (de) | 2010-06-15 |
KR101050568B1 (ko) | 2011-07-19 |
RU2009119394A (ru) | 2011-01-20 |
US8202993B2 (en) | 2012-06-19 |
EP2102207A1 (en) | 2009-09-23 |
JP2010511661A (ja) | 2010-04-15 |
TW200838518A (en) | 2008-10-01 |
ES2344131T3 (es) | 2010-08-18 |
KR20090079255A (ko) | 2009-07-21 |
US20080139553A1 (en) | 2008-06-12 |
AU2007328995B2 (en) | 2012-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20092342L (no) | Azaspiroderivativater | |
NO20091766L (no) | Spiro-piperidinderivater | |
NO20074592L (no) | Acetylenyl-pyrazolo-pyrimidinderivater som mGluR2-antagonister | |
NO20073719L (no) | Kjemiske forbindelser | |
NO20092149L (no) | Spiro-piperidinderivater | |
NO20070199L (no) | Substituerte kinazoloner som anti-kreftmidler | |
NO20082709L (no) | Kjemiske forbindelser | |
NO20073876L (no) | Pyrazolopyrimidinderivater som mGluR2-antagonister | |
NO20081729L (no) | Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer | |
NO20072784L (no) | Pyridenkarboksamidderivater for anvendelse som anticancer midler | |
NO20070489L (no) | 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer. | |
NO20055688L (no) | Organiske forbindelser | |
NO20085100L (no) | Nye forbindelser | |
NO20063469L (no) | Polyeheterosykliske forbindelser og deres anvendelse som metabotrofe glutamat reseptorantagonister | |
NO20074258L (no) | Pyridin-2-karboksamidderivater som MGLUR5 antagonister | |
NO20054414L (no) | Dihydropteridinoner, metoder for deres fremstilling og bruk av disse som medisiner | |
NO20060324L (no) | [1,8]Naftyridin-2-oner og relaterte forbindelser for behandling av Schizofreni | |
NO20090328L (no) | Nye forbindelser 385 | |
NO20091683L (no) | Kjemiske forbindelser | |
NO20076197L (no) | Nye 2-azetidinonderivater anvendbare i behandling av hyperlipidemiske tilstander | |
NO20076195L (no) | Nye 2-azetidinonderivater for behandling av hyperlipidemiske sykdommer | |
NO20084363L (no) | 2-Substituerte 4-benzylftalazinonderivater som histamin H1- og H3-antagonister | |
NO20083905L (no) | Nye pyron-indol derivater og fremgangsmate for deres fremstilling | |
EA200801184A1 (ru) | Производные пипередин-4-ил-пиридазин-3-иламина как быстро диссоциирующие антагонисты рецептора дофамина 2 | |
NO20092689L (no) | Quinuclidinolderivater som muskarin reseptorantagonister |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |